Identifeye aims to integrate retinal screenings into standard physical exams to improve early detection of diabetic retinopathy (DR), a leading cause of blindness in adults.

The system uses AI to enable non-clinicians to capture high-quality retinal images, making DR screenings more accessible and reducing the need for specialized training.

Identifeye plans to launch its product in 2025, focusing on retail clinics and health systems, with ongoing development of autonomous AI screening capabilities.

Identifeye Working To Put Automated Diabetic Retinopathy Screening In Primary Care Settings

More from R&D

More from Leadership